Macrogenics Analyst Ratings
BMO Capital Maintains Market Perform on Macrogenics, Lowers Price Target to $5
BMO Capital Maintains Market Perform on Green Plains, Lowers Price Target to $17
Bloomin Brands Analyst Ratings
UBS Adjusts Cryoport Price Target to $7 From $17, Maintains Neutral Rating
Redfin Price Target Maintained With a $8.00/Share by Wedbush
Qualys Price Target Cut to $160.00/Share From $190.00 by Wedbush
UBS Adjusts Price Target on Rapid7 to $59 From $65, Maintains Buy Rating
GoPro Analyst Ratings
IDEAYA Biosciences Price Target Maintained With a $54.00/Share by Wedbush
Hamilton Lane Analyst Ratings
Keefe, Bruyette & Woods Maintains Market Perform on Hamilton Lane, Raises Price Target to $145
Buy Rating Reaffirmed for Stoke Therapeutics Amidst Clinical Progress and Strong Financial Footing
Revolve Group Price Target Maintained With a $19.00/Share by Wedbush
Steven Madden Price Target Maintained With a $41.00/Share by Wedbush
Steven Madden Analyst Ratings
Flywire Analyst Ratings
Skyline Champion Analyst Ratings
Wells Fargo Maintains Overweight on Flywire, Lowers Price Target to $20
Baldwin Insurance Price Target Raised to $39.00/Share From $34.00 by Wells Fargo